Bayer Avelox Uncomplicated Skin Infection Use Clears FDA
Bayer is studying Avelox for complicated skin infections, the company said following the approval of the fluoroquinolone for uncomplicated skin infection.
Bayer is studying Avelox for complicated skin infections, the company said following the approval of the fluoroquinolone for uncomplicated skin infection.